McFadden Michael E. 4
4 · Urovant Sciences Ltd. · Filed Oct 17, 2018
Insider Transaction Report
Form 4
McFadden Michael E.
CCO of Urovant Sciences, Inc.
Transactions
- Award
Stock Option (Right to Buy)
2018-10-15+4,750→ 4,750 totalExercise: $13.65Exp: 2028-10-14→ Common Shares (4,750 underlying)
Footnotes (1)
- [F1]25% of the total shares underlying the option shall vest and become exercisable on October 1, 2019; the remaining shares vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.